Haverford Trust Company’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-767
| Closed | -$251K | – | 399 |
|
|
2024
Q4 | $251K | Sell |
767
-94
| -11% | -$30.8K | ﹤0.01% | 359 |
|
|
2024
Q3 | $258K | Buy |
861
+73
| +9% | +$21.9K | ﹤0.01% | 375 |
|
|
2024
Q2 | $260K | Buy |
788
+102
| +15% | +$33.6K | ﹤0.01% | 370 |
|
|
2024
Q1 | $271K | Hold |
686
| – | – | ﹤0.01% | 346 |
|
|
2023
Q4 | $242K | Sell |
686
-45
| -6% | -$15.8K | ﹤0.01% | 341 |
|
|
2023
Q3 | $274K | Buy |
+731
| New | +$274K | ﹤0.01% | 323 |
|
|
2022
Q2 | – | Sell |
-2,357
| Closed | -$968K | – | 363 |
|
|
2022
Q1 | $968K | Hold |
2,357
| – | – | 0.01% | 199 |
|
|
2021
Q4 | $1.11M | Hold |
2,357
| – | – | 0.01% | 194 |
|
|
2021
Q3 | $1M | Hold |
2,357
| – | – | 0.01% | 199 |
|
|
2021
Q2 | $846K | Buy |
+2,357
| New | +$846K | 0.01% | 211 |
|